These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16222887)

  • 21. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Jiang YW; Pang L; Fang QH; Ma YM
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The stady of pulmonary hypertension and plasma BNP values in respiratory diseases].
    Yano S; Kobayashi K; Kato K; Ikeda T
    Nihon Kokyuki Gakkai Zasshi; 2006 Feb; 44(2):99-103. PubMed ID: 17228802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma activity of B-type natriuretic peptide in patients with biventricular heart failure versus those with right heart failure due to chronic obstructive pulmonary disease.
    Flessas N; Alexanian I; Parissis J; Kremastinos D; Lekakis J; Filippatos G
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):476-80. PubMed ID: 24983267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptide levels in patients with COPD and normal right ventricular function.
    Gemici G; Erdim R; Celiker A; Tokay S; Ones T; Inanir S; Oktay A
    Adv Ther; 2008 Jul; 25(7):674-80. PubMed ID: 18563310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
    Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
    Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
    Shang YP; Lai L; Chen J; Zhang F; Wang X
    J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD.
    Stolz D; Breidthardt T; Christ-Crain M; Bingisser R; Miedinger D; Leuppi J; Mueller B; Tamm M; Mueller C
    Chest; 2008 May; 133(5):1088-94. PubMed ID: 18339792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BNP concentrations and exercise capacity assessment with cardiopulmonary stress test in cyanotic adult patients with congenital heart diseases.
    Trojnarska O; Gwizdala A; Katarzynski S; Katarzynska A; Oko-Sarnowska Z; Grajek S; Kramer L
    Int J Cardiol; 2010 Mar; 139(3):241-7. PubMed ID: 19042041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.
    Leuchte HH; Holzapfel M; Baumgartner RA; Ding I; Neurohr C; Vogeser M; Kolbe T; Schwaiblmair M; Behr J
    J Am Coll Cardiol; 2004 Mar; 43(5):764-70. PubMed ID: 14998614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of heart failure on the classification of COPD severity.
    Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
    J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro B-type natriuretic peptide (N-BNP) levels in cystic fibrosis patients.
    Ben Tov A; Paret G; Sela BA; Blau H; Hegesh J; Efrati O; Yahav Y; Augarten A
    Pediatr Pulmonol; 2007 Aug; 42(8):699-703. PubMed ID: 17588252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
    COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patent foramen ovale among patients with mild chronic obstructive pulmonary disease and unexplained hypoxia.
    Kilic H; Balci MM; Aksoy MN; Bilgin E; Gülsoy KG; Yeter E; Acikel S; Akdemir R
    Echocardiography; 2010 Jul; 27(6):687-90. PubMed ID: 20345439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of plasma B-type natriuretic peptide levels with shunt size in young adults with atrial septal defect.
    Uz O; Aparcı M; Acar G; Kardesoglu E; Kaplan O; Yiginer O; Isilak Z; Ozcelik F; Cebeci BS
    Echocardiography; 2011 Feb; 28(2):243-7. PubMed ID: 21210834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
    Wu SJ; Chen P; Jiang XN; Liu ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.